Overview

Acute Concussion and Melatonin

Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
In this study, the investigator plans a randomized trial of melatonin versus standard care post acute pediatric concussion. The investigator hypothesizes that patients with acute concussions managed with melatonin will have decreased risk of prolonged concussion symptoms and faster resolution of concussion symptoms.
Phase:
Phase 1
Details
Lead Sponsor:
Children's National Research Institute
Treatments:
Melatonin